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Background: For satisfactory Salmonella control, good biosecurity along the pork production chain is crucial,
although additional control measures on-farm need to be considered. This study evaluated the effect of two poten-
tial control measures against the spread of Salmonella Typhimurium via a transmission experiment with 56 piglets
(3–15 weeks of age): two groups were orally vaccinated with 107 - 108 Colony Forming Units (CFU)/2 mL of a new
attenuated Salmonella Typhimurium vaccine ‘Salmoporc-ΔrfaJ’ with DIVA capacities (Differentiation between In-
fected and Vaccinated Animals) (n = 2x16); the feed of one group was additionally supplemented with coated
calcium-butyrate salt. Two weeks post vaccination, four pigs per group were orally challenged with 107 CFU/2 mL
of a Salmonella Typhimurium strain 112910a. Both groups were compared with a positive (challenged/untreated;
n = 16) and negative (unchallenged/untreated; n = 8) control group. Until six weeks post challenge, blood, individual
faecal and finally tissue samples were examined. Adjusted transmission ratios ‘Ra’ were estimated, based on the
challenge strain isolation from faecal and/or tissue samples.
Results: In both intervention groups, Ra values were lower compared to the positive control group, although these
differences were not significant. In the combination group DIVA vaccine + coated butyrate, less non-challenged
contact animals excreted Salmonella and less tissue samples were found Salmonella-positive in all pigs, when
compared to the positive control group (P < 0.01). Seroconversion was detected in none of the vaccinated animals
before challenge, when using a commercial lipopolysaccharide (LPS) ELISA targeting only Salmonella O-antigens,
deleted in this vaccine. This was in contrast with an in-house whole-cell ELISA testing for various Salmonella
antigens, in which Salmonella-specific antibodies were found pre-challenge in the serum of the vaccinated pigs.
Conclusions: Both interventions showed a limited, non-significant reduction of Salmonella transmission between
piglets. They may have applications towards Salmonella control and surveillance. Firstly, the number of Salmonella
excreting contact pigs was significantly lower in the group where vaccination was combined with coated calcium-
butyrate salt in the feed; secondly, the new vaccine confirmed its DIVA capacity. Therefore, these interventions merit
further research with larger sample sizes, to optimize their use for Salmonella programmes.
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Salmonella infections are one of the most important and
widely distributed foodborne diseases in the European
Union. Contaminated pork has been linked to 34.5% of
the human outbreaks of Salmonella enterica subspecies
enterica serovar Typhimurium (SalmonellaTyphimurium)
in the EU [1]. Therefore, any reduction of the Salmonella
risk by pork products would contribute to the protection
of human health. However, the control of Salmonella in
pork production remains a significant challenge in the
preharvest sector. Implementing good biosecurity and op-
erating a high standard of hygiene is crucial in every link
of the pork production chain [2], but additional control
measures on-farm are indispensable [3].
Vaccination is one possible supplementary measure that
can be implemented in Salmonella control programmes.
It is currently used successfully in the poultry industry of
several European countries [4,5]. Also in pigs, various vac-
cine studies have demonstrated a significant decrease in
clinical signs and excretion of Salmonella [2,6-8]. Most
European serosurveillance programmes however, rely on
commercial lipopolysaccharide (LPS) ELISAs, which do
not allow differentiation between Salmonella-specific anti-
bodies induced by vaccination or by infection [9]. Several
DIVA vaccines (Differentiation of Infected and Vaccinated
Animals) have recently been developed [10,11], of which
one vaccine, a Salmonella Typhimurium strain without
the ‘rfaJ’ gene, induces antibodies undetectable with LPS
ELISA [11]. Another control measure with promising fea-
tures against Salmonella infections, is the oral administra-
tion of butyrate, especially in its coated form [12,13]. Not
only does this organic acid enhance pig performance by
improving gut function, it also down-regulates Salmonella
virulence gene expression [14]. None of these studiesTable 1 Design of the transmission study with the samples/ac
age
Age of the
pigs in
weeks
Sampling or action (Group) Frequ
3 - 8 Floor faeces (group A, B, C, D) Once/w
9 - 15 Rectal faeces (group A, B, C, D) Twice/
3 - 15 Blood (group A, B, C, D) Once/w
3 - 15 Feed supplementation (group B) Ad libit
4 + 7 Oral vaccination (group A, B) Twice:
(n = 16
9 Oral challenge (group A, B, C) Once;
replace
n = 12)
15 Rectal faeces, Ileum + content, Caecum + content,
Ileocaecal Lnn, Tonsils (group A, B, C, D)
At nec
aTwo ELISA tests were performed: (1) commercial HerdChek Swine Salmonella (IDEXhowever, have investigated the effect on the actual trans-
mission rate of Salmonella between pigs.
The aim of the present study was to evaluate the effect
of a commercial vaccine that was modified to a DIVA
vaccine strain, and its combination with coated calcium-
butyrate salt in the feed on the transmission of Salmon-
ella Typhimurium in weaned pigs.
Methods
Study design
At three weeks of age, 56 Salmonella-negative piglets were
randomly assigned to four different stables in the experi-
mental animal facilities of CODA-CERVA, with two sepa-
rated pens each (Table 1). Group A (n = 2 × 8) was orally
vaccinated at four and seven weeks of age with 107 - 108
Colony Forming Units (CFU)/2 mL of a live LPS-mutant
Salmonella Typhimurium strain, named the ‘Salmoporc-
ΔrfaJ’ strain, in reference to the deletion of the ‘rfaJ’ gene
[11] in a commercial vaccine (Salmoporc®, IDT Biologika);
group B (n = 2 × 8) was vaccinated similarly and received
additionally feed supplemented with 0.3% coated calcium-
butyrate salt throughout the experiment (Globamax Perfor-
mant, Sanluc International); a positive control group C (chal-
lenged/untreated; n = 2 × 8) and a negative control group D
(unchallenged/untreated; n= 8) were included as well. Each
group, except the negative control group, consisted of two
replicates to increase the power of the experiment.
The pens were separated with solid concrete partitions
and had a semi-solid concrete floor (half grid, half rub-
ber mats). The pig stocking density was 0.42 m2 per ani-
mal. In all groups, the same starter and pig meal without
antimicrobials was administered throughout the study,
(i.e. from arrival in the experimental facilities at three
weeks of age until euthanasia at 15 weeks of age), excepttions and diagnostics/products, as a function of the pigs’
ency (Number of pigs) Diagnostic method or product
eek (1 pool/pen; n = 7) Isolation (ISO 6579 Annex D)
week (individually; n = 56) Isolation (ISO 6579 Annex D)
eek (n = 56) ELISA a
um (n = 15) Coated calcium-butyrate salt (Globamax
Performant,, Sanluc International)
primer + boost 107 - 108 CFU of DIVA vaccine
(A); n = 15(B)) ‘Salmoporc-ΔrfaJ’
in a separate stable, with
ment 24 h later (2 pigs/pen;
107 CFU of nalidixic acid-resistant
Salmonella Typhimurium strain 112910a
ropsy (n = 56) Isolation (ISO 6579 Annex D)
X); (2) In-house whole-cell ELISA (Leyman et al., 2011).
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scribed above. The pigs were housed at natural day-
night rhythm with ad libitum access to water and feed.
Each group of eight pigs was provided with a rubber ball
as environmental enrichment.
With the exception of the negative control group, two
pigs per pen were orally challenged at nine weeks of age
with 107 CFU/2 mL of a nalidixic acid-resistant Salmonella
Typhimurium strain 112910a [15] in a separate pen.
Twenty-four hours later, these challenged ‘seeder’ pigs were
replaced with the naive, non-challenged contact pigs (0
Days Post Contact or ‘DPC’), and all pigs were monitored
until 15 weeks of age (42 DPC). This day (0 DPC) was con-
sidered as the start of the transmission experiment. Before
challenge at nine weeks of age, individual blood samples
and pooled faecal pen samples were taken once a week.
After challenge, blood samples were obtained once a week,
whereas individual rectal faeces were collected twice a
week from all pigs. At necropsy, rectal faeces, ileum, ileal
content, caecum, caecal content, ileocaecal lymph nodes
and tonsils were sampled. The experimental design was ap-
proved by the Animal Care and Ethical Committee of the
IPH-VAR (Approval number 100412–02).
Sample analysis
All faecal samples were examined using the ISO 6579
Annex D method [16]. Firstly, the samples were diluted
1:10 in buffered peptone water (BPW, Bio-Rad) and aerob-
ically incubated for 16-20 h at 37°C. Of this solution,
0.1 mL was inoculated on a modified semi-solid Rappaport-
Vassiliadis plate (MSRV, Bio-Rad) (one sample per plate)
and aerobically incubated for 46-50 h at 41°C. After this
period, a loopful of the growth area in this MSRV enrich-
ment must be plated out on a xylose lysine deoxycholate
agar plate (XLD, Bio-Rad) and another agar for choice. In
this study was opted for a brilliant green agar plate (BGA,
Lab M), known to allow satisfactory growth of both the
vaccine and challenge strain. The latter plate was supple-
mented with 20 μg/mL nalidixic acid for differentiating
these Salmonella Typhimurium strains. For 21-27 h, both
plates were given an aerobic incubation at 37°C. A Salmon-
ella-suspected colony on the BGA plates was expected to
be only the nalidixic acid-resistant challenge strain, whereas
on the XLD plates, colonies of both the challenge and vac-
cine strain were able to grow. From these XLD or BGA
plates, one Salmonella-suspected colony was inoculated in
triple sugar iron agar (TSI, Bio-Rad) and lysine decarboxyl-
ase bouillon (Oxoid) and incubated for 18-24 h at 37°C for
final confirmation. After preparation, the tissue samples
were investigated similarly to the faecal samples.
The blood samples were allowed to coagulate at room
temperature and were then centrifuged for 15 min at
1200 g. The serum collected thereafter, was diluted
twenty-fold and analysed with two ELISA tests: (1) acommercial ELISA kit based on LPS O-antigens of ser-
ogroup B, C1 and D (HerdChek Swine Salmonella,
IDEXX); (2) an in-house whole-cell ELISA, based on a
variety of surface-antigens on the Salmonella Typhimur-
ium strain 112910a [11]. Consequently, antibodies against
the ‘Salmoporc-ΔrfaJ’ vaccine strain, which expresses no
O-antigens, should only be detectable with this whole-cell
ELISA. Other Salmonella strains on the other hand, will
be detected in both ELISA tests. Optical densities (OD) in
both ELISAs were determined by photo spectrometry with
a 650 nm filter. Samples with a Sample-to-Positive (S/P)
ratio ≥0.25 (= OD% ≥10) were defined as positive.
Statistical analysis
Based upon all faecal samples, the numbers of excreting
pigs were compared via generalized estimating equations
(GEE), using the proc genmod procedure in SAS 9.2
(SAS Institute Inc., USA). For this, a binomial distribu-
tion and logit link function were used. Bacteriological re-
sults from the tissue samples (ileum, ileal content,
caecum, caecal content, ileocaecal lymph nodes, tonsils)
were compared between groups (DIVA vaccine, DIVA
vaccine + Coated Butyrate, Positive Control) using logis-
tic regression analysis in SAS 9.2. P-values below 0.05
were considered significant.
The transmission of Salmonella Typhimurium in each
group was estimated on the basis of the stochastic ‘SI’ in-
fection model (Susceptible-Infectious), using an ‘adjusted’
transmission ratio ‘Ra’ for the observed period of six
weeks, which is derived from the basic reproduction ratio
R0 for the entire infectious period [17]. In this study, each
intervention group contained n = 8 piglets, of which ini-
tially two challenged animals were infectious (I0 = 2) and
six contact animals were susceptible (S0 = 6). An Ra value
below or above one means respectively, that each infected
animal will pass the infection on to less or more than one
naive contact animal during the observed period of six
weeks. This Ra value was estimated via the Maximum
Likelihood Estimation (MLE) based on the final size of the
study, which represents the total number of contact infec-
tions [18]. A contact animal was considered infected,
when at least one sample was positive in: i) individual fae-
ces, or ii) ileum, caecum and/or their content, or iii) ileo-
caecal lymph nodes and/or tonsils, or iv) all tissues and/or
all faeces collected. Ra values were calculated for each of
the previous four categories, and significant differences
between groups were assessed [19].
Results
Bacteriological examination
In each group, all pooled faecal samples taken prior to chal-
lenge were Salmonella-negative. All individual faecal sam-
ples from the negative control group remained negative
during the whole experiment. One contact pig of group B
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and was excluded from the study (no respiratory pathogens
could be identified at necropsy).
After challenge, no significant differences between the
groups were observed in the numbers of Salmonella-ex-
creting animals, when considering all challenged and non-
challenged pigs (Figure 1). If the challenged seeder pigs
were not taken into account for all 11 sampling points
however, significantly fewer Salmonella-positive samples
were obtained in group B (9/121), when compared to
group C (30/132) (P < 0.01). At the end of the trial, respect-
ively 8/12 (67%), 7/11 (64%) and 12/12 (100%) non-
challenged contact pigs from group A, B and C had
excreted Salmonella in their feces on at least one sampling
occasion (Additional file 1: Table S1). From all necropsy
samples of both challenged and non-challenged pigs, 27,
13 and 41% were found positive for the challenge strain
in group A, B and C, respectively, with a significant
difference between group B and C (P < 0.01) (Table 2).
Respectively 6/12 (50%), 2/11 (18%) and 10/12 (83%) non-
challenged contact pigs from group A, B and C had one
tissue sample or more colonized with Salmonella. Both
the faecal shedding and tissue colonization are presented
individually in Additional file 1: Table S1.
The adjusted transmission ratios Ra, based on the fae-
cal and/or tissue results of all challenged and non-
challenged pigs, were lower in all four categories in both
vaccinated groups A and B, when compared to the un-
vaccinated group C (Table 3). These differences between
groups were not significant (P > 0.05).
Serological examination
In the commercial LPS-ELISA, all pigs were seronegative
for Salmonella-specific antibodies before challengeFigure 1 Proportion of Salmonella challenge strain positive faecal sam
(■) DIVA vaccine; (●) DIVA vaccine + Coated calcium-butyrate salt; (✖) Posi
lenge with 107 CFU/2 mL Salmonella Typhimurium of 2 seeder pigs per group(Figure 2). In contrast, the in-house whole-cell ELISA
showed that the mean S/P ratio increased already one
week before challenge in both vaccinated groups A and
B, whereas the increase occurred two weeks after chal-
lenge in the positive control group C (results not
shown).
Discussion
The increase of global meat consumption during the
next decades is expected to be largely due to increases
in pork [20]. The reduction of any pig-related public
health risk is therefore of considerable importance. Sal-
monella Typhimurium represents a most relevant pig-
associated risk despite current control measures [1], and
was therefore selected for the present transmission ex-
periment in weaned pigs. This study aimed to assess the
effect of a DIVA vaccine [11], with and without coated
calcium-butyrate salt in the feed.
As a consequence of the study design (transmission
experiment), in which the treatment was applied to all
pigs before challenge, the combined treatment effect on
both the excretion of the inoculated pigs and the suscep-
tibility of the contact animals is evaluated. This is an im-
portant difference with efficacy studies in which mainly
the susceptibility is assessed and not the combined effect
[6,21,22]. This study concept also allows to better simu-
late the field situation, namely infection of a treated pig
which may subsequently infect other treated pigs in the
area. Several other bacterial diseases have been investi-
gated in similar experiments [18,23-30]. As the Ra values
were higher than one in this experiment, the present in-
terventions will not eradicate infection with Salmonella
Typhimurium during the studied period. However, the
treated groups demonstrated non-significantly lower Raples per groups, as a function of time (DPC: days post contact).
tive Control; (✱) Negative Control. DPC = −1: Replacement and oral chal-
of 8 pigs, with reintroduction of seeders in their original pen 24 h later.
Table 2 Results of the descriptive and logistic regression analysis of the necropsy samples positive for the Salmonella
challenge strain in the three groups
Group § Parameters Different necropsy samples All
necropsy
samples
Ileum Ileal Content Caecum Caecal Content Ileocaecal Lnn Tonsils
A) DIVA vaccine (n = 16) Number 4 a 4 ab 6 a 5 ab 3 a 4 a 26 ab
(Proportion) (25%) (25%) (38%) (31%) (19%) (25%) (27%)
OR* 0.67 0.21 2.23 0.23 0.49 0.25 0.55
P-value 0.66 0.10 0.38 0.07 0.41 0.18 0.05
B) DIVA vaccine + Coated Butyrate (n = 15) Number 2 a 1 a 2 a 3 a 1 a 3 a 12 a
(Proportion) (13%) (7%) (13%) (20%) (7%) (20%) (13%)
OR* 0.25 0.03 0.34 0.12 0.15 0.14 0.30
P-value 0.18 0.01 0.33 0.02 0.10 0.08 <0.01
C) Positive control (n = 16) (ref) Number 5 a 8 b 4 a 10 b 5 a 7 a 39 b
(Proportion) (31%) (50%) (25%) (63%) (31%) (44%) (41%)
a, bNumbers in a column, not sharing the same letters in superscript, are significantly different: ileal and caecal content (P < 0.02) and all necropsy
samples (P < 0.01).
*Odds Ratios (OR) >1 or <1, define the intervention of group A or B as a risk or protective factor, respectively, for having Salmonella-positive tissue samples, when
compared to the positive control group.
§A) oral vaccination at four and seven weeks of age with 107 - 108 CFU/2 mL of the live ‘Salmoporc-ΔrfaJ’ strain; B) vaccination of (A) plus feed supplemented with
0.3% coated calcium-butyrate salt; C) positive control that was challenged without being treated.
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control group. Therefore, a more distinct reducing effect
might be expected when observing pigs for a longer
time, as was demonstrated in previous efficacy studies
[7,31,32], which investigated the efficacy of vaccination,
acidified drinking water, and fermented liquid feed dur-
ing the entire finishing period, respectively. This ex-
pected enlarged difference between groups might be
explained by a prolonged potential spread of Salmonella
in the untreated control group, while no further spread
is expected in the treatment groups.
Concerning vaccination, different studies have demon-
strated a reduction of Salmonella shedding and/or
Salmonella seroprevalence in pigs [6,7,10,33,34]. Vaccine-
induced antibodies should be distinguishable however,
from those induced by infection in order not to hamperTable 3 Adjusted reproduction ratio Ra [95% confidence inter
categories
Group § Individual faeces a Ile
A) DIVA vaccine (n = 16) 1.76 [1.02; 9.01]
B) DIVA vaccine + Coated Butyrate (n = 15) 2.52 [0.99; 9.62]
C) Positive control (n = 16) * +∞ [1.88; +∞]
P-value (A, C) 0.22
P-value (A, B) 0.47
P-value (B, C) 0.19
aUsing the ISO method 6579 Annex D, a pig was considered as infected, if at least o
positive during the transmission period.
§A) oral vaccination at four and seven weeks of age with 107 - 108 CFU/2 mL of the
0.3% coated calcium-butyrate salt; C) positive control that was challenged without
*+∞ = plus infinity.monitoring programmes based on serology. Selke et al.
[10] developed a DIVA vaccine of which the induced anti-
bodies were not detectable in their in-house ELISA, but
the DIVA vaccine of Leyman et al. [11] induced antibodies
undetectable with a commercial LPS ELISA that is com-
monly used in serosurveillance programmes (HerdChek
Swine Salmonella, IDEXX). Consequently, the latter vac-
cine would be suitable for use in European serosurveil-
lance programmes, whereas the first vaccine would not. In
the present study, the method of Leyman et al. [11] was
therefore applied on the commercial vaccine Salmoporc®,
resulting in the ‘Salmoporc-ΔrfaJ’ strain. The commercial
vaccine Salmoporc® has proven its effectiveness previously
[33] using the same administration procedure as the
current study, and Leyman et al. [11] demonstrated a
similar protection after immunization with either a wild-val] for groups A, B, C, as a function of four different
um/content/Caecum/
content a
Ileocaecal Lnn/
tonsils a
All tissues/individual
faeces a
1.03 [0.56; 3.95] 0.77 [0.35; 3.80] 2.37 [1.46; 10.02]
0.50 [0.17; 5.82] 0.37 [0.14; 4.64] 2.52 [0.99; 9.62]
2.52 [1.02; 9.01] 1.19 [0.70; 7.18] +∞ [1.88; +∞]
0.25 0.21 0.37
0.38 0.21 0.27
0.31 0.07 0.19
ne of the samples of four marked categories in every column was found
live ‘Salmoporc-ΔrfaJ’strain; B) vaccination of (A) plus feed supplemented with
being treated.
Figure 2 Weekly detection (LPS ELISA, IDEXX) of Salmonella-specific antibodies (mean S/P ratio), as a function of time (DPC: days post
contact). (■) DIVA vaccine; (●) DIVA vaccine + Coated calcium-butyrate salt; (✖)Positive Control; (✱) Negative Control. DPC=−1: Replacement and
oral challenge with 107 CFU/2 mL Salmonella Typhimurium of 2 seeder pigs per group of 8 pigs, with reintroduction of seeders in their original pen 24 h later.
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Therefore, the ‘Salmoporc-ΔrfaJ’ strain used in this study
was expected to have the same protective effect as the
Salmoporc® parent strain. Whereas the in vivo study of
Leyman et al. [11] involved four unchallenged vaccinated
piglets, this new DIVA strain was evaluated in 16 chal-
lenged piglets. Although the ‘Salmoporc-ΔrfaJ’ strain as
single intervention resulted in a limited non-significant
reduction of transmission, serological surveillance using
the commercial ELISA-tests remains applicable. There-
fore, it may be considered a promising tool in future
Salmonella surveillance, worthy of further investigation
for optimization.
Previous studies with organic acids in the feed showed
both reducing [22,35] and non-reducing [36,37] capaci-
ties on Salmonella excretion or antibody induction. In
this study, we opted for supplementing the feed with
coated calcium-butyrate, as earlier studies [12,13] have
shown that coating of fatty acids is needed to let them
reach the colonization sites (ileum, caecum and colon)
in their active form. In addition, the in-feed coated bu-
tyrate was combined with the current DIVA vaccine, as
these two control strategies are believed to be comple-
mentary. Namely, both strategies have a different work-
ing mechanism to combat Salmonella transmission, i.e.
the vaccination enhancing the host’s immune response
and the coated butyrate targeting Salmonella bacteria in
the gut environment and improving intestinal epithelial
growth. In the current study, Salmonella transmission in
the DIVA vaccine + butyrate group was not significantly
different from the one in both other challenged groups.
However, in this group significantly less non-challenged
contact animals excreted Salmonella and significantly
less organ samples of all challenged and non-challengedpigs were found Salmonella-positive, when compared to
in the positive control group. An additional beneficial ef-
fect was thus observed in the combination group, in
comparison with the DIVA vaccine intervention on its
own, which might be explained by this dual approach to
Salmonella infection. However, the combination of both
strategies would also incur considerable additional costs,
in comparison with the single interventions. Therefore,
more research including a cost-benefit analysis and while
observing pigs for a longer period (e.g. from weaning till
market age), is warranted.
Conclusions
Both interventions in this study did not show a signifi-
cant reduction of Salmonella Typhimurium transmis-
sion. Significantly less contact pigs excreted Salmonella
however, in the group where vaccination was combined
with coated butyrate in the feed, and the vaccine itself
confirmed its ‘DIVA’ capacity. Therefore, these interven-
tions merit further research to improve their applicabil-
ity in Salmonella control programmes.Additional file
Additional file 1: Table S1. Presentation of the individual Salmonella-
positive faecal and necropsy samples (grey) per sampling occasion and
tissue, respectively.
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